SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.

UNLABELLED This study investigated alterations in regional cerebral blood flow (rCBF) in patients with Parkinson's disease using statistical parametric mapping (SPM). METHODS Noninvasive rCBF measurements using 99mTc-ethyl cysteinate dimer (ECD) SPECT were performed on 28 patients with Parkinson's disease and 48 age-matched healthy volunteers. The Parkinson's disease patients were divided into two groups, 16 patients with Hoehn and Yahr stage I or II and 12 patients with Hoehn and Yahr stage III or IV. We used the raw data (absolute rCBF parametric maps) and the adjusted rCBF images in relative flow distribution (normalization of global CBF for each subject to 50 mL/100 g/min with proportional scaling) to compare these groups with SPM. RESULTS In patients with stage I or II Parkinson's disease, we found a diffuse decrease in absolute rCBF in the whole brain with sparing of the central gray matter, hippocampus and right lower temporal lobe compared with healthy volunteers. Adjusted rCBF increased in both putamina and the right hippocampus. In patients with stage III or IV disease, rCBF decreased throughout the whole brain. Adjusted rCBF increased bilaterally in the putamina, globi pallidi, hippocampi and cerebellar hemispheres (dentate nuclei) and in the left ventrolateral thalamus, right insula and right inferior temporal gyrus. CONCLUSION SPM analysis showed that significant rCBF changes in Parkinson's disease accompanied disease progression and related to disease pathophysiology in the functional architecture of thalamocortex-basal ganglia circuits and related systems.

[1]  D. Moon,et al.  Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  D E Kuhl,et al.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.

[3]  S. Bentin,et al.  Regional cerebral blood flow in parkinsonism Measurement before and after levodopa , 1978, Journal of Neurological Sciences.

[4]  Lee-Tzuu Chang,et al.  A Method for Attenuation Correction in Radionuclide Computed Tomography , 1978, IEEE Transactions on Nuclear Science.

[5]  E. Melamed,et al.  Cerebral blood flow and cognitive impairment in Parkinson's disease , 1985, Neurology.

[6]  Yoshiharu Yonekura,et al.  Noninvasive Quantitative Measurements of Regional Cerebral Blood Flow Using Technetium-99m-L,L-ECD SPECT Activated with Acetazolamide: Quantification Analysis by Equal-Volume-Split 99mTc-ECD Consecutive SPECT Method , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[8]  K. Wester,et al.  Stereotaxic thalamotomy--experiences from the levodopa era. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[9]  T Jones,et al.  Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.

[10]  Karl J. Friston,et al.  Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[12]  N. Lassen,et al.  Retention of 99mTc-bicisate in the human brain after intracarotid injection. , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  M Otsuka,et al.  Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[14]  J R Moeller,et al.  Regional metabolic correlates of surgical outcomes following unilateral pallidotomy for parkinson's disease , 1996, Annals of neurology.

[15]  B. F. Logan,et al.  The Fourier reconstruction of a head section , 1974 .

[16]  Marcus E. Raichle,et al.  Regional blood flow in herniparkinsonism , 1985, Neurology.

[17]  O. Devinsky,et al.  Stereotactic ventral pallidotomy for Parkinson's disease , 1995, Neurology.

[18]  R J Wise,et al.  The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. , 1985, Brain : a journal of neurology.

[19]  T. Gasser,et al.  123I‐iodobenzamide‐SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism , 1992, Neurology.

[20]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[21]  N P Quinn,et al.  Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. , 1997, Brain : a journal of neurology.

[22]  Karl J. Friston,et al.  Assessing the significance of focal activations using their spatial extent , 1994, Human brain mapping.

[23]  M. Ichise,et al.  SPECT imaging of dopamine receptors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  R Harrop,et al.  Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.